These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Biochemical characterization of the M712T-mutation of the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosaminekinase in hereditary inclusion body myopathy. Weidemann W; Reinhardt A; Thate A; Horstkorte R Neuromuscul Disord; 2011 Dec; 21(12):824-31. PubMed ID: 21873062 [TBL] [Abstract][Full Text] [Related]
28. Expression and secretion of wild type and mutant GNE proteins in Dictyostelium discoideum. Grover S; Aslam S; Sharma V; Arya R CNS Neurol Disord Drug Targets; 2014; 13(7):1263-72. PubMed ID: 25230235 [TBL] [Abstract][Full Text] [Related]
29. Novel GNE mutations in hereditary inclusion body myopathy patients of non-Middle Eastern descent. Saechao C; Valles-Ayoub Y; Esfandiarifard S; Haghighatgoo A; No D; Shook S; Mendell JR; Rosales-Quintero X; Felice KJ; Morel CF; Pietruska M; Darvish D Genet Test Mol Biomarkers; 2010 Apr; 14(2):157-62. PubMed ID: 20059379 [TBL] [Abstract][Full Text] [Related]
30. Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations. Mori-Yoshimura M; Monma K; Suzuki N; Aoki M; Kumamoto T; Tanaka K; Tomimitsu H; Nakano S; Sonoo M; Shimizu J; Sugie K; Nakamura H; Oya Y; Hayashi YK; Malicdan MC; Noguchi S; Murata M; Nishino I J Neurol Sci; 2012 Jul; 318(1-2):100-5. PubMed ID: 22507750 [TBL] [Abstract][Full Text] [Related]
31. Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy. Niethamer TK; Yardeni T; Leoyklang P; Ciccone C; Astiz-Martinez A; Jacobs K; Dorward HM; Zerfas PM; Gahl WA; Huizing M Mol Genet Metab; 2012 Dec; 107(4):748-55. PubMed ID: 23122659 [TBL] [Abstract][Full Text] [Related]
32. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. Huizing M; Rakocevic G; Sparks SE; Mamali I; Shatunov A; Goldfarb L; Krasnewich D; Gahl WA; Dalakas MC Mol Genet Metab; 2004 Mar; 81(3):196-202. PubMed ID: 14972325 [TBL] [Abstract][Full Text] [Related]
37. GNE myopathy associated with congenital thrombocytopenia: a report of two siblings. Izumi R; Niihori T; Suzuki N; Sasahara Y; Rikiishi T; Nishiyama A; Nishiyama S; Endo K; Kato M; Warita H; Konno H; Takahashi T; Tateyama M; Nagashima T; Funayama R; Nakayama K; Kure S; Matsubara Y; Aoki Y; Aoki M Neuromuscul Disord; 2014 Dec; 24(12):1068-72. PubMed ID: 25257349 [TBL] [Abstract][Full Text] [Related]
38. Magnesium may help patients with recessive hereditary inclusion body myopathy, a pathological review. Darvish D Med Hypotheses; 2003 Jan; 60(1):94-101. PubMed ID: 12450772 [TBL] [Abstract][Full Text] [Related]
39. The tetrameric structure of sialic acid-synthesizing UDP-GlcNAc 2-epimerase from Ko TP; Lai SJ; Hsieh TJ; Yang CS; Chen Y J Biol Chem; 2018 Jun; 293(26):10119-10127. PubMed ID: 29764940 [TBL] [Abstract][Full Text] [Related]
40. Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches. Crowe KE; Zygmunt DA; Heller K; Rodino-Klapac L; Noguchi S; Nishino I; Martin PT J Neuromuscul Dis; 2022; 9(1):53-71. PubMed ID: 34511508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]